HemoSense to Hold Fiscal 2007 Second Quarter Financial Results Conference Call on May 1

  
    
  
  
    
      HemoSense, Inc. (AMEX:HEM) today announced that it will release 
      financial results for the fiscal 2007 second quarter ended March 31, 
      2007 after market close on Tuesday, May 1, 2007. HemoSense management 
      will host an investment community conference call beginning at 4:30 p.m. 
      Eastern time (1:30 p.m. Pacific time) to discuss those results and 
      answer questions.
    
    
      Individuals interested in participating in the conference call may do so 
      by dialing [phone] for domestic callers, or [phone] for 
      international callers. Those interested in listening to the conference 
      call live via the Internet may do so by visiting the Investors section 
      of the company’s Web site at www.hemosense.com.
    
    
      A telephone replay will be available for 48 hours following the 
      conclusion of the call by dialing [phone] for domestic callers, 
      or [phone] for international callers, and entering reservation 
      code 5406225. A webcast replay will be available for 30 days by visiting 
      the Investors section on the HemoSense Web site.
    
    
      About HemoSense
    
    
      HemoSense is a point-of-care diagnostic healthcare company that 
      develops, manufactures and markets easy-to-use, handheld blood 
      coagulation systems for monitoring patients taking warfarin. The 
      HemoSense INRatio® system, used by healthcare 
      professionals and patients themselves, consists of a small monitor and 
      disposable test strips. It provides accurate and convenient measurement 
      of blood clotting time, or PT/INR values. Routine measurements of PT/INR 
      are necessary for the safe and effective management of the patient's 
      warfarin dosing. INRatio is sold in the United States and 
      internationally. For more information, visit www.hemosense.com.